• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.

作者信息

Kang Jung Hun, Lee Gyeong-Won, Shin Seong Hoon, Bruera Eduardo

出版信息

J Pain Symptom Manage. 2013 Aug;46(2):e15-7. doi: 10.1016/j.jpainsymman.2013.02.009. Epub 2013 May 13.

DOI:10.1016/j.jpainsymman.2013.02.009
PMID:23680581
Abstract
摘要

相似文献

1
Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.一名患有门静脉血栓形成的胃癌患者在接受低剂量缓释羟考酮和纳洛酮治疗后出现阿片类药物戒断综合征。
J Pain Symptom Manage. 2013 Aug;46(2):e15-7. doi: 10.1016/j.jpainsymman.2013.02.009. Epub 2013 May 13.
2
Prolonged-release naloxone can cause systemic opioid withdrawal.长效纳洛酮可引起全身性阿片类药物戒断反应。
Eur J Pain. 2009 Oct;13(9):1001; author reply 1002-3. doi: 10.1016/j.ejpain.2009.05.018. Epub 2009 Jul 16.
3
Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.羟考酮/纳洛酮制剂经非肠道给药或口服滥用时可导致急性戒断症状。
Clin Toxicol (Phila). 2015;53(8):815-8. doi: 10.3109/15563650.2015.1060486. Epub 2015 Jun 25.
4
Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.羟考酮与纳洛酮复方缓释片用于中重度慢性疼痛患者的镇痛疗效和安全性
J Pain. 2008 Dec;9(12):1144-54. doi: 10.1016/j.jpain.2008.06.014. Epub 2008 Aug 16.
5
Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.使用缓释纳曲酮进行维持性阿片类药物阻断治疗期间出现的戒断反应。
Addiction. 2008 Aug;103(8):1399-401. doi: 10.1111/j.1360-0443.2008.02252.x.
6
A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.一项关于盐酸羟考酮/盐酸纳曲酮缓释胶囊（ALO-02）用于中重度慢性非癌性疼痛患者的多中心、为期12个月的开放标签单臂安全性研究。
J Opioid Manag. 2014 Nov-Dec;10(6):423-36. doi: 10.5055/jom.2014.0239.
7
The attractiveness of opposites: agonists and antagonists.异性相吸：激动剂与拮抗剂。
J Pain Palliat Care Pharmacother. 2015 Mar;29(1):67-9. doi: 10.3109/15360288.2014.1003680. Epub 2015 Feb 2.
8
Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.盐酸羟考酮/纳洛酮控释片治疗神经病理性疼痛的疗效观察-来自一项大型观察性研究。
Expert Opin Pharmacother. 2012 Feb;13(3):299-311. doi: 10.1517/14656566.2012.648615. Epub 2012 Jan 6.
9
A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy.腹腔镜子宫切除术后羟考酮控释片与羟考酮-纳洛酮控释片的比较。
Acta Anaesthesiol Scand. 2013 Apr;57(4):509-17. doi: 10.1111/aas.12051. Epub 2013 Jan 10.
10
High doses of oxycodone-naloxone combination may provide poor analgesia.高剂量羟考酮-纳洛酮复方制剂可能提供不佳的镇痛效果。
Support Care Cancer. 2011 Sep;19(9):1471-2. doi: 10.1007/s00520-011-1205-x. Epub 2011 Jun 9.

引用本文的文献

1
Biased Opioid Receptor Agonists: Balancing Analgesic Efficacy and Side-Effect Profiles.偏向性阿片受体激动剂：平衡镇痛疗效与副作用特征
Int J Mol Sci. 2025 Feb 21;26(5):1862. doi: 10.3390/ijms26051862.
2
Analysis of vascular thrombus and clinicopathological factors in prognosis of gastric cancer: A retrospective cohort study.胃癌预后中血管血栓与临床病理因素分析：一项回顾性队列研究
World J Gastrointest Oncol. 2024 Aug 15;16(8):3436-3444. doi: 10.4251/wjgo.v16.i8.3436.
3
Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine.
右美托咪定治疗羟考酮/纳洛酮引发的阿片类药物戒断综合征
J Hosp Palliat Care. 2023 Mar 1;26(1):18-21. doi: 10.14475/jhpc.2023.26.1.18.
4
Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study.盐酸羟考酮/纳洛酮与酒石酸布托啡诺用于真实世界慢性非癌痛治疗的比较：一项观察性和药物遗传学研究。
Sci Rep. 2022 Jun 16;12(1):10126. doi: 10.1038/s41598-022-13085-5.
5
Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.纳地美定用于日本阿片类药物引起的便秘和慢性非癌性疼痛患者：开放标签III期研究。
J Pain Res. 2018 Dec 24;12:127-138. doi: 10.2147/JPR.S175900. eCollection 2019.
6
Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in Australia.澳大利亚自发报告的与曲马多和羟考酮/纳洛酮相关的药物不良事件。
Ther Adv Drug Saf. 2018 Apr;9(4):197-205. doi: 10.1177/2042098618760939. Epub 2018 Mar 25.
7
Complications with oxycodone and naloxone.羟考酮和纳洛酮的并发症。
Aust Prescr. 2017 Aug;40(4):156-157. doi: 10.18773/austprescr.2017.018. Epub 2017 Aug 1.
8
High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain.高剂量固定剂量复方羟考酮/纳洛酮缓释片治疗慢性癌痛的疗效和耐受性。
Support Care Cancer. 2017 Oct;25(10):3051-3058. doi: 10.1007/s00520-017-3709-5. Epub 2017 May 3.
9
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis.口服羟考酮/纳洛酮与普瑞巴林对肺癌伴神经性疼痛患者的镇痛效果及耐受性：一项观察性分析
Onco Targets Ther. 2016 Jul 4;9:4043-52. doi: 10.2147/OTT.S108144. eCollection 2016.
10
Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.针对阿片类药物引起的肠道功能障碍症状患者的新兴疗法。
Drug Des Devel Ther. 2015 Apr 16;9:2215-31. doi: 10.2147/DDDT.S32684. eCollection 2015.